| Financial Year |
March 31 2023 |
| Monetary Funds |
704,812,268.48 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
88,523,735.04 |
| Accounts Receivable |
469,501,386.89 |
| Advances to Suppliers |
28,273,716.22 |
| Other Receivables |
35,811,403.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
3,764,978.85 |
| Dividend Receivable |
-- |
| Inventories |
326,121,381.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
115,443,282.74 |
| Total Current Assets |
1,798,102,043.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,916,064.06 |
| Investment Properties |
-- |
| Fixed Assetes |
682,550,627.71 |
| Under-construction Projects |
53,173,410.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,369,562.22 |
| R&D expenses |
3,550,572.64 |
| Goodwill |
50,429,905.09 |
| Long-Term Deferred and Prepaid Expenses |
32,496,493.53 |
| Deferred Income Tax Assets |
68,066,385.92 |
| Other Non-Current Assets |
55,522,463.11 |
| Sub-Total of Non-Current Assets |
1,265,370,290.11 |
| Total Assets |
3,063,472,333.27 |
| Short-Term Loans |
690,003,418.28 |
| Trading Financial liabilities |
-- |
| Notes Payable |
183,274,294.77 |
| Accounts Payable |
288,297,313.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
35,442,022.24 |
| Taxes Payable |
8,796,045.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
95,599,504.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
133,148,476.71 |
| Other Current Liabilities |
19,019,325.96 |
| Sub-Total of Current Liabilities |
1,460,279,669.23 |
| Long-term Loans |
172,160,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,508,293.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
328,366,929.73 |
| Total Liabilities |
1,788,646,598.96 |
| Paid-In Capital(Or Share Stock) |
465,746,427.00 |
| Capital Surplus |
614,056,742.35 |
| Surplus Reserve |
42,565,633.34 |
| LESS:Treasury Stock |
50,009,916.42 |
| Undistributed Profits |
128,748,430.27 |
| Minority Stockholder's Interest |
70,395,885.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,204,429,849.08 |
| Owner's Equity（Stockholder's Equity） |
1,274,825,734.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,063,472,333.27 |
